The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)
Bangladesh · Delayed Price · Currency is BDT 314.80
+2.50 (0.80%)
At close: Sep 3, 2026
DSE:IBNSINA Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 335.07 | 314.9 | 365.23 | 232.23 | 342.61 | 281.24 |
Short-Term Investments | 42.66 | 22.5 | 166.79 | - | - | - |
Cash & Short-Term Investments | 377.73 | 337.4 | 532.02 | 232.23 | 342.61 | 281.24 |
Cash Growth | -9.26% | -36.58% | 129.09% | -32.22% | 21.82% | 40.68% |
Accounts Receivable | 286.18 | 189.86 | 195.83 | 96.1 | 43.61 | 23.61 |
Other Receivables | 2.91 | 6.19 | 6.69 | 11.03 | 10.22 | 3.66 |
Receivables | 289.09 | 196.05 | 202.51 | 107.13 | 53.83 | 27.27 |
Inventory | 1,878 | 1,808 | 1,585 | 1,157 | 1,008 | 782.16 |
Other Current Assets | 656.91 | 503.71 | 300.44 | 340.44 | 232.54 | 367.16 |
Total Current Assets | 3,202 | 2,845 | 2,620 | 1,836 | 1,637 | 1,458 |
Property, Plant & Equipment | 6,681 | 4,621 | 3,826 | 3,103 | 2,596 | 2,331 |
Long-Term Investments | 41.17 | 46.66 | 54.17 | 57.22 | 56.11 | 56.87 |
Other Long-Term Assets | 17.57 | 33.72 | 9.05 | 8.8 | 21.66 | - |
Total Assets | 9,942 | 7,547 | 6,509 | 5,006 | 4,310 | 3,845 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 578.62 | 396.18 | 260.3 | 282.31 | 166.18 | 231.65 |
Accrued Expenses | 367.04 | 246.61 | 249.51 | 218.04 | 97.59 | 137.68 |
Short-Term Debt | 2,195 | 953.68 | 1,243 | 512.14 | 534.29 | 377.5 |
Current Portion of Long-Term Debt | 89.58 | 119.45 | 62.3 | 72.21 | 70.18 | 65.16 |
Current Portion of Leases | 2.59 | 23.8 | 25.54 | 22.41 | 22.06 | 2.37 |
Current Income Taxes Payable | 687.49 | 495.25 | 284.58 | 212.06 | 165.56 | 279.3 |
Other Current Liabilities | 177.64 | 241.6 | 193.32 | 142.3 | 68.17 | 61.62 |
Total Current Liabilities | 4,098 | 2,477 | 2,318 | 1,461 | 1,124 | 1,155 |
Long-Term Debt | 1,286 | 974.71 | 530.49 | 330.09 | 368.01 | 419.62 |
Long-Term Leases | - | - | 24.8 | 51.34 | 74.75 | 1.99 |
Pension & Post-Retirement Benefits | 2.34 | 0.99 | 1.19 | 1.01 | 0.73 | 0.09 |
Long-Term Deferred Tax Liabilities | 104.9 | 96.46 | 101.18 | 105.81 | 117.72 | 118.87 |
Other Long-Term Liabilities | - | 0 | 0 | -0 | - | - |
Total Liabilities | 5,491 | 3,549 | 2,976 | 1,950 | 1,685 | 1,696 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 312.44 | 312.44 | 312.44 | 312.44 | 312.44 | 312.44 |
Retained Earnings | 4,054 | 3,630 | 3,194 | 2,711 | 2,293 | 1,834 |
Comprehensive Income & Other | -20.48 | -15.54 | -8.61 | -2.27 | -0.69 | 0.15 |
Total Common Equity | 4,346 | 3,927 | 3,497 | 3,021 | 2,604 | 2,146 |
Minority Interest | 104.81 | 70.95 | 35.88 | 35.05 | 20.66 | 3.35 |
Shareholders' Equity | 4,451 | 3,998 | 3,533 | 3,056 | 2,625 | 2,150 |
Total Liabilities & Equity | 9,942 | 7,547 | 6,509 | 5,006 | 4,310 | 3,845 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 3,573 | 2,072 | 1,886 | 988.19 | 1,069 | 866.65 |
Net Cash (Debt) | -3,183 | -1,717 | -1,328 | -723.75 | -695.57 | -580.23 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -101.87 | -54.94 | -42.52 | -23.16 | -22.26 | -18.57 |
Filing Date Shares Outstanding | 31.24 | 31.24 | 31.24 | 31.24 | 31.24 | 31.24 |
Total Common Shares Outstanding | 31.24 | 31.24 | 31.24 | 31.24 | 31.24 | 31.24 |
Working Capital | -895.74 | 368.68 | 302.22 | 374.96 | 512.52 | 302.55 |
Book Value Per Share | 139.10 | 125.69 | 111.94 | 96.68 | 83.36 | 68.69 |
Tangible Book Value | 4,346 | 3,927 | 3,497 | 3,021 | 2,604 | 2,146 |
Tangible Book Value Per Share | 139.10 | 125.69 | 111.94 | 96.68 | 83.36 | 68.69 |
Construction In Progress | 4,085 | 1,932 | 1,139 | 572.47 | 144.25 | 111.41 |